India has one of the greatest young populations and is the second most populated country in the world, home to 1.21 billion people. More than 30% of the population is made up of infants, kids, and teenagers, with the largest percentage being in the 1–5 age range. The population is expected to grow by about 26 million children annually as a result of the growing number of children. The pharmaceutical industry was expected to gain greatly from a compound annual growth rate (CAGR) of 5% during the fiscal years 2017 and 2021.
In the pediatric pharmaceutical sector, this rising need offers a fantastic opportunity. Our knowledgeable staff is here to help if you're interested in working with a respectable pediatric PCD pharmaceutical company in Chandigarh. Get in touch with us right now to learn more about franchise possibilities and join this growing sector.
Why Choosing an Indian Paediatric PCD Company Is a Good Option
Due to its fast rising population, India is a country with a high need for pharmaceutical formulations. The healthcare industry is expanding quickly as consumers look for high-quality drugs at reasonable costs to treat a variety of health issues, including as ageing, malnutrition, climate change, and new diseases.
The demand for pediatric drugs has increased at an unprecedented rate as a result of government expenditures in the pharmaceutical sector and an increase in the birth rate. This has contributed to the expansion of the Pharma PCD franchise market in India, offering businesspeople and medical professionals profitable prospects. A well-regulated industry structure, favorable market circumstances, and rising healthcare product demand have made the pharmaceutical franchise sector well-positioned for significant growth in the years to come.
Parents are giving their children's medical requirements more importance as they realize that the next generation will shape our country. As one of India's top pharmaceutical franchises, Cafoli is dedicated to providing the greatest healthcare options for kids across the country by satisfying the rising need for premium pediatric medications.